Somatostatin analogs and intermediates thereto

Chemistry of carbon compounds – Miscellaneous organic carbon compounds – C-metal

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424177, C07C10352, A61K 3700

Patent

active

040616266

ABSTRACT:
The tetradecapeptides ##STR1## in which Y is Gly or D-Ala are described along with corresponding non-toxic pharmaceutically-acceptable acid addition salts as well as intermediates useful in the synthesis of the tetradecapeptides. The tetradecapeptide in which Y is Gly as well as its pharmaceutically acceptable acid addition salts exhibit as their principal activity the in vivo inhibition of the release of gastric acid. The tetradecapeptide in which Y is D-Ala as well as its pharmaceutically acceptable acid addition salts exhibit as their principal activity the in vivo stimulation of the release of growth hormone.

REFERENCES:
patent: 3842066 (1974-10-01), McKinley et al.
patent: 3842067 (1974-10-01), Sarantakis
patent: 3882098 (1975-05-01), Sarantakis
patent: 3896105 (1975-07-01), Chai et al.
patent: 3904594 (1975-09-01), Guillemin et al.
patent: 3917581 (1975-11-01), Immer et al.
patent: 3931140 (1976-01-01), Sarantakis
L. Ferland, et al.; Molecular and Cellular Endocrinology 4, 79-86 (1976).
Biochem. and Biophysical Research Comm. 65, (1975), 746-750.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Somatostatin analogs and intermediates thereto does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Somatostatin analogs and intermediates thereto, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Somatostatin analogs and intermediates thereto will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1549985

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.